UK scientists are to research the potential of psilocybin to boost the effects of talking therapies for people with an end-of-life diagnosis.
The UK not-for-profit organisation, Heroic Hearts, is to undertake groundbreaking research exploring the potential of psilocybin for treating traumatic brain injury in veterans.
A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.
American medical cannabis company Goodness Growth Holdings has announced it is branching out in to psychedelics medicine.